Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study

Table 7

Antibiotic resistance rates of gram-negative isolates in patients after hyperthermic intraperitoneal chemotherapy (HIPC) operation.

Antibiotic	Number (%) of resistant isolates
	ESBL Klebsiella pneumoniae	Acinetobacter baumannii	Providencia stuartii	Pseudomonas aeruginosa (CRP)	Escherichia coli	ESBL Escherichia coli	Stenotrophomonas maltophilia	Enterobacter species	Proteus species	Total
	1	6	1	6	3	7	1	2	2	29
Cefotaxime		4 (70%)						1 (50%)	1 (50%)
Cefuroxime		3 (50%)			2 (50%)			1 (50%)	1 (50%)
Ciprofloxacin	1 (100%)	5 (80%)		1 (11%)	3 (100%)	6 (85.7%)
Gentamicin		5 (80%)		2 (33%)	3 (100%)	3 (42.9%)
Nitrofurantoin			1 (100%)
Piperacillin		1 (10%)		1 (11%)	3 (100%)				1 (50%)
Piperacillin/tazobactam				1 (11%)	3 (100%)
Sulfamethoxazole/trimethoprim	1 (100%)	4 (70%)			3 (100%)	5 (71.4%)
Amikacin		5 (80%)
Ceftazidime		5 (80%)		2 (33%)			1 (100%)	2 (100%)
Cefepime		5 (80%)		1 (11%)	3 (100%)			1 (33%)	1 (50%)
Imipenem		5 (80%)		4 (67%)
Meropenem		4 (70%)		4 (67%)
Amoxicillin/clavulanic acid			1 (100%)		2 (67%)			1 (50%)	1 (50%)
Ampicillin			1 (100%)		2 (67%)			1 (50%)
Levofloxacin				1 (11%)		3 (42.9%)	1 (100%)	2 (100%)
Ceftriaxone		1 (10%)
Colistin		1 (10%)
Ceftriaxone		4 (70%)
Cefotaxime				1 (11%)				1 (50%)
Ampicillin/sulbactam
Cefazolin
Aztreonam